MESO Stock Summary and Trading Ideas (Mesoblast Limited - American Depositary Shares | NASDAQ:MESO)

Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD), and for moderate to severe acute respiratory distress syndrome (ARDS) and others.

Mesoblast Limited - American Depositary Shares trades on the NASDAQ stock market under the symbol MESO.

As of April 25, 2024, MESO stock price declined to $6.12 with 85,176 million shares trading.

MESO has a beta of 2.53, meaning it tends to be more sensitive to market movements. MESO has a correlation of 0.05 to the broad based SPY ETF.

MESO has a market cap of $698.12 million. This is considered a Small Cap stock.

Last quarter Mesoblast Limited - American Depositary Shares reported $2 million in Revenue and -$.28 earnings per share. This fell short of revenue expectation by $-231,000 and exceeded earnings estimates by $.02.

In the last 3 years, MESO stock traded as high as $17.98 and as low as $1.61.

MESO stock has underperformed the market in the last year with a return of -8.9%, while SPY returned +23.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in MESO shares. However, MESO has outperformed the market in the last 3 month and 2 week periods, returning +245.8% and +5.5%, while SPY returned +3.6% and -2.5%, respectively. This indicates MESO has been having a stronger performance recently.

MESO support price is $5.73 and resistance is $6.71 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MESO stock will trade within this expected range on the day.